Patent holdings for IPC class A61K 31/216

Total number of patents in this class: 2352

10-year publication summary

177
190
205
157
192
199
157
150
123
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Sichuan Jiuzhang Biological Science and Technology Co., Ltd
70
61
Apnimed, Inc. (Delaware)
53
32
io Therapeutics, Inc.
121
27
Novartis AG
10511
24
Kao Corporation
5006
24
Corsair Pharma, Inc.
37
16
Rush University Medical Center
308
16
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1345
16
Impax Laboratories, LLC
29
16
The Regents of the University of California
20315
15
Infirst Healthcare Limited
60
15
Sichuan Jiuzhang Bio-technology Co., Ltd.
15
15
SpringWorks Therapeutics, Inc.
151
15
Allergan, Inc.
2310
14
Horizon Therapeutics, LLC
25
14
Insmed Incorporated
248
13
Genfit
278
12
Hisamitsu Pharmaceutical Co., Inc.
782
12
Mati Therapeutics Inc.
62
12
The Research Foundation for The State University of New York
1672
12
Other owners 1971